These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 28595544)

  • 1. Nano-carriers for the Treatment of Tuberculosis.
    Gilani SJ; Ameeduzzafar ; Jafar M; Shakil K; Imam SS
    Recent Pat Antiinfect Drug Discov; 2017; 12(2):95-106. PubMed ID: 28595544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.
    Gelperina S; Kisich K; Iseman MD; Heifets L
    Am J Respir Crit Care Med; 2005 Dec; 172(12):1487-90. PubMed ID: 16151040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-based drug delivery optimization for tuberculosis treatment: A review.
    Dahanayake MH; Jayasundera ACA
    J Microbiol Methods; 2021 Feb; 181():106127. PubMed ID: 33359155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis - a critical review.
    Singh J; Garg T; Rath G; Goyal AK
    Drug Deliv; 2016 Jun; 23(5):1676-98. PubMed ID: 26289212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured Therapeutic Carriers for Tuberculosis Treatment: Approaches & Challenges.
    Ullah Z; Athar MT; Samad A
    Recent Pat Antiinfect Drug Discov; 2017; 12(2):128-137. PubMed ID: 28990537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in nanotechnology for diagnosis and treatment of tuberculosis.
    Banyal S; Malik P; Tuli HS; Mukherjee TK
    Curr Opin Pulm Med; 2013 May; 19(3):289-97. PubMed ID: 23429097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology based drug delivery system(s) for the management of tuberculosis.
    Pandey R; Khuller GK
    Indian J Exp Biol; 2006 May; 44(5):357-66. PubMed ID: 16708887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhalable porous particles as dual micro-nano carriers demonstrating efficient lung drug delivery for treatment of tuberculosis.
    Campos Pacheco JE; Yalovenko T; Riaz A; Kotov N; Davids C; Persson A; Falkman P; Feiler A; Godaly G; Johnson CM; Ekström M; Pilkington GA; Valetti S
    J Control Release; 2024 May; 369():231-250. PubMed ID: 38479444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoemulsion-Based Transdermal Drug Delivery System for the Treatment of Tuberculosis.
    Wais M; Aqil M; Goswami P; Agnihotri J; Nadeem S
    Recent Pat Antiinfect Drug Discov; 2017; 12(2):107-119. PubMed ID: 28571549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoemulsion for the Effective Treatment and Management of Anti-tubercular Drug Therapy.
    Beg S; Saini S; Imam SS; Rahman M; Swain S; Hasnain MS
    Recent Pat Antiinfect Drug Discov; 2017; 12(2):85-94. PubMed ID: 28480833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology-Based Drug Delivery Systems for Treatment of Tuberculosis--A Review.
    da Silva PB; de Freitas ES; Bernegossi J; Gonçalez ML; Sato MR; Leite CQ; Pavan FR; Chorilli M
    J Biomed Nanotechnol; 2016 Feb; 12(2):241-60. PubMed ID: 27305759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How can nanoparticles contribute to antituberculosis therapy?
    Costa-Gouveia J; Aínsa JA; Brodin P; Lucía A
    Drug Discov Today; 2017 Mar; 22(3):600-607. PubMed ID: 28137645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage Targeted Cellular Carriers for Effective Delivery of Anti-Tubercular Drugs.
    Agnihotri J; Singh S; Wais M; Pathak A
    Recent Pat Antiinfect Drug Discov; 2017; 12(2):162-183. PubMed ID: 29219058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis.
    Machelart A; Salzano G; Li X; Demars A; Debrie AS; Menendez-Miranda M; Pancani E; Jouny S; Hoffmann E; Deboosere N; Belhaouane I; Rouanet C; Simar S; Talahari S; Giannini V; Villemagne B; Flipo M; Brosch R; Nesslany F; Deprez B; Muraille E; Locht C; Baulard AR; Willand N; Majlessi L; Gref R; Brodin P
    ACS Nano; 2019 Apr; 13(4):3992-4007. PubMed ID: 30822386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnology and tuberculosis: An old disease with new treatment strategies.
    Macêdo DCDS; Cavalcanti IDL; Medeiros SMFRDS; Souza JB; Lira Nogueira MCB; Cavalcanti IMF
    Tuberculosis (Edinb); 2022 Jul; 135():102208. PubMed ID: 35567896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery.
    Sosnik A; Carcaboso AM; Glisoni RJ; Moretton MA; Chiappetta DA
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):547-59. PubMed ID: 19914315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Present status of nanoparticle research for treatment of tuberculosis.
    Shegokar R; Al Shaal L; Mitri K
    J Pharm Pharm Sci; 2011; 14(1):100-16. PubMed ID: 21501557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colloidal carriers: a rising tool for therapy of tuberculosis.
    Gupta S; Kumar P; Gupta MK; Vyas S
    Crit Rev Ther Drug Carrier Syst; 2012; 29(4):299-53. PubMed ID: 22746187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.